Exact Mass: 567.1787604000001
Exact Mass Matches: 567.1787604000001
Found 131 metabolites which its exact mass value is equals to given mass value 567.1787604000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Neoacrimarine H
Neoacrimarine H is found in citrus. Neoacrimarine H is an alkaloid from the roots of Citrus paradisi (grapefruit). Alkaloid from the roots of Citrus paradisi (grapefruit). Neoacrimarine H is found in citrus.
Met Kinase Inhibitor
Cefcapene pivoxil
Hydroxy Bosentan
C27H29N5O7S (567.1787604000001)
GalNAcGlcNAcThrNAc
[Chemical] Source; sea squirt H-antigen (limited periodate oxide)
N-(2,5,12-dimethoxy-3,11,16-trimethyl-1,4,10,13-tetraoxo-1,5,6,7,9,10,13,14,14a,15-decahydro-4H-6,15-epiazano-benzo[4,5]azocino[1,2-b]isoquinolin-9-ylmethyl)-2-oxo-propionamide|Saframycin C
C29H33N3O9 (567.2216688000001)
O-beta-D-galactopyranosyl-(1-->4)-O-beta-D-galactopyranosyl-(1-->3)-O-beta-D-arabinofuranosyl-(1-->1)-cytosine
Cys Glu Met Trp
C24H33N5O7S2 (567.1821308000001)
Cys Glu Trp Met
C24H33N5O7S2 (567.1821308000001)
Cys Met Glu Trp
C24H33N5O7S2 (567.1821308000001)
Cys Met Trp Glu
C24H33N5O7S2 (567.1821308000001)
Cys Pro Trp Tyr
C28H33N5O6S (567.2151438000001)
Cys Pro Tyr Trp
C28H33N5O6S (567.2151438000001)
Cys Trp Glu Met
C24H33N5O7S2 (567.1821308000001)
Cys Trp Met Glu
C24H33N5O7S2 (567.1821308000001)
Cys Trp Pro Tyr
C28H33N5O6S (567.2151438000001)
Cys Trp Tyr Pro
C28H33N5O6S (567.2151438000001)
Cys Tyr Pro Trp
C28H33N5O6S (567.2151438000001)
Cys Tyr Trp Pro
C28H33N5O6S (567.2151438000001)
Glu Cys Met Trp
C24H33N5O7S2 (567.1821308000001)
Glu Cys Trp Met
C24H33N5O7S2 (567.1821308000001)
Glu Glu Gln Tyr
Glu Glu Tyr Gln
Glu Met Cys Trp
C24H33N5O7S2 (567.1821308000001)
Glu Met Trp Cys
C24H33N5O7S2 (567.1821308000001)
Glu Gln Glu Tyr
Glu Gln Tyr Glu
Glu Trp Cys Met
C24H33N5O7S2 (567.1821308000001)
Glu Trp Met Cys
C24H33N5O7S2 (567.1821308000001)
Glu Tyr Glu Gln
Glu Tyr Gln Glu
Met Cys Glu Trp
C24H33N5O7S2 (567.1821308000001)
Met Cys Trp Glu
C24H33N5O7S2 (567.1821308000001)
Met Glu Cys Trp
C24H33N5O7S2 (567.1821308000001)
Met Glu Trp Cys
C24H33N5O7S2 (567.1821308000001)
Met Met Thr Trp
C25H37N5O6S2 (567.2185142000001)
Met Met Trp Thr
C25H37N5O6S2 (567.2185142000001)
Met Thr Met Trp
C25H37N5O6S2 (567.2185142000001)
Met Thr Trp Met
C25H37N5O6S2 (567.2185142000001)
Met Trp Cys Glu
C24H33N5O7S2 (567.1821308000001)
Met Trp Glu Cys
C24H33N5O7S2 (567.1821308000001)
Met Trp Met Thr
C25H37N5O6S2 (567.2185142000001)
Met Trp Thr Met
C25H37N5O6S2 (567.2185142000001)
Pro Cys Trp Tyr
C28H33N5O6S (567.2151438000001)
Pro Cys Tyr Trp
C28H33N5O6S (567.2151438000001)
Pro Trp Cys Tyr
C28H33N5O6S (567.2151438000001)
Pro Trp Tyr Cys
C28H33N5O6S (567.2151438000001)
Pro Tyr Cys Trp
C28H33N5O6S (567.2151438000001)
Pro Tyr Trp Cys
C28H33N5O6S (567.2151438000001)
Gln Glu Glu Tyr
Gln Glu Tyr Glu
Gln Tyr Glu Glu
Thr Met Met Trp
C25H37N5O6S2 (567.2185142000001)
Thr Met Trp Met
C25H37N5O6S2 (567.2185142000001)
Thr Trp Met Met
C25H37N5O6S2 (567.2185142000001)
Trp Cys Glu Met
C24H33N5O7S2 (567.1821308000001)
Trp Cys Met Glu
C24H33N5O7S2 (567.1821308000001)
Trp Cys Pro Tyr
C28H33N5O6S (567.2151438000001)
Trp Cys Tyr Pro
C28H33N5O6S (567.2151438000001)
Trp Glu Cys Met
C24H33N5O7S2 (567.1821308000001)
Trp Glu Met Cys
C24H33N5O7S2 (567.1821308000001)
Trp Met Cys Glu
C24H33N5O7S2 (567.1821308000001)
Trp Met Glu Cys
C24H33N5O7S2 (567.1821308000001)
Trp Met Met Thr
C25H37N5O6S2 (567.2185142000001)
Trp Met Thr Met
C25H37N5O6S2 (567.2185142000001)
Trp Pro Cys Tyr
C28H33N5O6S (567.2151438000001)
Trp Pro Tyr Cys
C28H33N5O6S (567.2151438000001)
Trp Thr Met Met
C25H37N5O6S2 (567.2185142000001)
Trp Tyr Cys Pro
C28H33N5O6S (567.2151438000001)
Trp Tyr Pro Cys
C28H33N5O6S (567.2151438000001)
Tyr Cys Pro Trp
C28H33N5O6S (567.2151438000001)
Tyr Cys Trp Pro
C28H33N5O6S (567.2151438000001)
Tyr Glu Glu Gln
Tyr Glu Gln Glu
Tyr Pro Cys Trp
C28H33N5O6S (567.2151438000001)
Tyr Pro Trp Cys
C28H33N5O6S (567.2151438000001)
Tyr Gln Glu Glu
Tyr Trp Cys Pro
C28H33N5O6S (567.2151438000001)
Tyr Trp Pro Cys
C28H33N5O6S (567.2151438000001)
Neoacrimarine H
methyl 3-acetyl-2-oxo-6-phenylsulfanyl-4-[(1S,2R)-1,2,3-triacetyloxypropyl]-3a,4,7,7a-tetrahydropyrano[3,4-d][1,3]oxazole-6-carboxylate
C25H29NO12S (567.1410394000001)
Phenyl 3-azido-3-deoxy-2,4,6-tris-O-(phenylmethyl)-1-thio-beta-D-glucopyranoside
Phenyl 4-azido-4-deoxy-2,3,6-tris-O-(phenylmethyl)-1-thio-beta-D-glucopyranoside
Bis[1,3-bis( 2-ethenyl)-1,1,3,3-tetramethyldisiloxane]platinum
2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid
C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent > C162996 - MDM2 Inhibitor
Exatecan mesilate hydrate
C25H30FN3O9S (567.1686702000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D004791 - Enzyme Inhibitors
(3E)-N-(3-chlorophenyl)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-N-methyl-2-oxo-1H-indole-5-sulfonamide
1-[2-(Benzhydryloxy)ethyl]-4-(3-iodo-4-azidophenethyl)piperazine
3-{4-[(2-ethoxy-7-{[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl}-1H-benzimidazol-1-yl)methyl]biphenyl-2-yl}-5-oxo-1,2,4-oxadiazol-4-ide
N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
C28H33N5O6S (567.2151438000001)
N-[[(2R,3S)-8-(2-benzofuranyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
C28H33N5O6S (567.2151438000001)
N-[[(4S,5R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
C26H34FN3O6S2 (567.1872956000001)
N-[[(4S,5S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
C26H34FN3O6S2 (567.1872956000001)
N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
C28H33N5O6S (567.2151438000001)
N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
C28H33N5O6S (567.2151438000001)
N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
C28H33N5O6S (567.2151438000001)
N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
C28H33N5O6S (567.2151438000001)
N-[[(4R,5S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
C26H34FN3O6S2 (567.1872956000001)
N-[[(4S,5S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
C26H34FN3O6S2 (567.1872956000001)
N-[[(4S,5R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
C26H34FN3O6S2 (567.1872956000001)
N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
C28H33N5O6S (567.2151438000001)
N-[[(4R,5R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
C26H34FN3O6S2 (567.1872956000001)
N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
C28H33N5O6S (567.2151438000001)
N-[[(4R,5S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
C26H34FN3O6S2 (567.1872956000001)
N-[[(4R,5R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
C26H34FN3O6S2 (567.1872956000001)
(1S)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-[(5-phenyl-3-isoxazolyl)methyl]-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1R)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-[(5-phenyl-3-isoxazolyl)methyl]-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[2-hydroxy-1-(7-methoxy-2-oxo-2H-chromen-6-yl)-3-oxobutyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[3-hydroxy-4-(7-methoxy-2-oxo-2H-chromen-8-yl)-2-methylbutan-2-yl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C25H33N3O10S (567.1886558000001)
N-[(2S,3R,4R,5R,6R)-2-[(2S,3R,4S,5S,6R)-5-acetamido-6-[(2S,3R)-3-acetamido-4-hydroxy-1-oxobutan-2-yl]oxy-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
GDC-6036-NH
GDC-6036-NH is from patent WO2020097537A2, and a precursor of compound 17 a/b. Compound 17 a/b is a RAS inhibitor and can be used in cancer research[1].